XML 27 R15.htm IDEA: XBRL DOCUMENT v3.21.2
SEGMENT REPORTING
 9 Months Ended
Sep. 30, 2021
Segment Reporting [Abstract]  
SEGMENT REPORTING

NOTE 9 – SEGMENT REPORTING

 

The Company classifies its business interests into reportable segments which are Trxade, Inc., Community Specialty Pharmacy, LLC, Integra Pharma, LLC and Other. Operating segments are defined as the components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision makers in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision makers direct the allocation of resources to operating segments based on the profitability, cash flows, and growth opportunities of each respective segment.

 SCHEDULE OF BUSINESS INTERESTS INTO REPORTABLE SEGMENTS

Nine Months Ended

September 30, 2021

  Trxade, Inc.  

Community Specialty Pharmacy,

LLC

   Integra Pharma, LLC   Other   Total 
Revenue  $3,653,269   $1,287,296   $2,511,270   $49,700   $7,501,535 
Gross Profit  $3,652,015   $123,470   $(319,104)  $49,362   $3,505,743 
Segment Assets  $1,487,657   $(404,174)  $563,396   $3,867,221   $5,514,101 
Segment Profit (Loss)  $1,511,809   $(89,025)  $(2,500,032)  $(3,454,295)  $(4,531,543)

 

Nine Months Ended

September 30, 2020

  Trxade, Inc.   Community Specialty Pharmacy, LLC   Integra Pharma, LLC   Other   Total 
Revenue  $4,268,619   $1,287,197   $9,548,512   $23,898   $15,128,226 
Gross Profit  $4,268,619   $119,946   $1,162,030   $23,615   $5,574,210 
Segment Assets  $1,828,345   $257,495   $3,118,945   $6,649,226   $11,854,011 
Segment Profit (Loss)  $2,655,734   $(88,756)  $762,149   $(3,553,020)  $(223,893)